May Thurner syndrome: Sixty years later
Romulo Armenta Flores1, Diego Armenta-Villalobos2, Esteban Ramirez-Centeno1
1Hospital Medica Campestre, Department of Cardiovascular Surgery, Leon, Guanajuato, Mexico.
Phlebology
|September 8, 2021
Summary
May-Thurner syndrome (MTS), once overlooked, is now recognized in vascular surgery. Advances in imaging and interventions have improved diagnosis and treatment, though overtreatment is a growing concern.
Area of Science:
- Vascular Surgery
- Venous Pathology
- Medical History
Background:
- May-Thurner syndrome (MTS) was first described 60 years ago.
- Historically underdiagnosed and undertreated, MTS is now a recognized vascular pathology.
- Recent decades show renewed interest in venous diseases, improving MTS recognition.
Purpose of the Study:
- To provide a historical review of May-Thurner syndrome.
- To describe significant advances in understanding and managing MTS.
- To outline current treatment strategies for May-Thurner syndrome.
Main Methods:
- Historical literature review.
- Analysis of diagnostic imaging advancements.
- Review of interventional procedures for venous conditions.
Main Results:
- MTS recognition has significantly increased over the past 20 years.
- Improved imaging and interventional techniques enhance diagnosis and treatment.
- The ease of diagnosis has led to concerns about potential overtreatment.
Conclusions:
- May-Thurner syndrome management has evolved considerably.
- Current diagnostic and treatment approaches require careful consideration to avoid overtreatment.
- Further research into optimal management strategies is warranted.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
73
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
73
01:22Mitral Stenosis I: Introduction
84
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
84
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
47
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
47
01:22Mitral Valve Prolapse II: Assessment and Management
74
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
74